177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer.

about

Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine

P2860

Q48107095-7ABBFDFF-AB5B-496E-8E59-4CE2D0C63510 Q57107703-19046C49-2CEE-458C-969B-08704A51D165

P2860

177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer.

Item

http://www.wikidata.org/entity/Q42371612

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.

@en

177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.

@nl

type

Item

label

177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.

@en

177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.

@nl

prefLabel

177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.

@en

177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.

@nl

P1476

177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.

@en

P2093

Christian Uprimny

http://www.w3.org/2001/XMLSchema#string

Finn E von Eyben

http://www.w3.org/2001/XMLSchema#string

Irene Virgolini

http://www.w3.org/2001/XMLSchema#string

Kalevi Kairemo

http://www.w3.org/2001/XMLSchema#string

Timo Kiljunen

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.

Lutetium 177 PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy.

Salvage radiation therapy following radical prostatectomy. A national Danish study.

Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: a case report.

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.

Clinical impact of 68 Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary ana

68Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic Therapy.

The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer.

(68)Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : Early efficacy after primary therapy.

P304

66112-66116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19805

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Timo Joensuu

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029496

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

P932

5630396

http://www.w3.org/2001/XMLSchema#string

177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer.

about

P2860

P2860

177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932